New Nicorette mini Lozenge Offers Convenient, Pocket-Sized Support to Help Smokers Looking to Quit

PARSIPPANY, N.J., April 27 /PRNewswire/ -- To better help meet the needs of smokers who are quitting, Nicorette® launched a mini-sized stop smoking lozenge that dissolves up to three-times faster than other stop smoking lozenges and can double a smoker's chances of successfully quitting versus placebo.  The new Nicorette mini Lozenge comes in a discreet pocket-size vial, so smokers can have it on hand to help quickly address craving and withdrawal symptoms associated with quitting smoking.

To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/gsk/43473/

(Photo: http://www.newscom.com/cgi-bin/prnh/20100427/MM84335 )

Some smokers will attempt to quit up to nine times before doing so successfully, and according to studies, a person's social networks can influence his or her decision to pick up smoking, or initiate quitting.  By seeking out support from friends, family, or other smokers, and utilizing available cessation tools such as nicotine replacement therapy (NRT), smokers increase their chances of quitting significantly.

"Smoking is an addiction, and when trying to quit, smokers may need help to address physical nicotine cravings as well as behavior change," said Dr. Drew Pinsky, addiction expert nationally known for his syndicated radio talk show, Loveline, and the VH1 shows, Celebrity Rehab and Sober House. "Products, like the new Nicorette mini Lozenge, can help address the physical symptoms associated with quitting and a new movement we've created online will help connect smokers, allowing them to share their stories and support."

Nicorette is launching a "mini Moments" contest on the new Nicorette Facebook® Page at www.Facebook.com/nicorette.  The page is designed to help connect smokers interested in quitting, allowing them to provide each other with support throughout the quitting process.

To enter the "mini Moments" contest, smokers can submit their most inspiring reason for wanting to quit smoking through the mini Moments Contest application on the Nicorette Facebook® Page by visiting www.Facebook.com/nicorette.  The contest offers them the chance to win an opportunity to meet addiction expert, Dr. Drew face-to-face, as well as a free course of new Nicorette mini Lozenge therapy to start them on their path to a smoke-free life.  Smokers joining the quit smoking movement will also be able to get tips from Dr. Drew on ways to overcome their nicotine addiction while sharing stories with others who are trying to quit.  

Visit www.Facebook.com/nicorette or www.Nicorette.com for more details.  Smokers looking to quit can also find Nicorette on Twitter by following @Nicorette (http://www.twitter.com/nicorette).

*Dr. Drew is a paid spokesperson by GlaxoSmithKline Consumer Healthcare; however, his opinions regarding smoking cessation are his own.

**Facebook® is registered trademark of Facebook, Inc.

About "mini Moments" Facebook® Contest

Nicorette is launching a "mini Moments" contest on the new Nicorette Facebook® Page. The site is designed to help connect smokers interested in quitting, allowing them to provide each other with support throughout the quitting process.  To enter the "mini Moments" contest, smokers can submit their most inspiring reason for wanting to quit smoking through the mini Moments Contest application on the Nicorette Facebook® Page for a chance to meet addiction expert, Dr. Drew Pinksy, attend a live recording of Dr. Drew's radio talk show, Loveline, and receive a full-course of new Nicorette mini Lozenge.  Go to www.Facebook.com/nicorette or www.Nicorette.com for more details.

About Nicorette®

Nicorette is a stop-smoking aid which provides fast, safe, controlled doses of nicotine to ease withdrawal from cigarettes.  Convenient to carry and use, Nicorette allows smokers to control how much nicotine they use, and gives them the added flexibility to treat strong or frequent cravings.  Nicorette gum is sugar-free and available in strengths of 2 mg (for smokers of less than 25 cigarettes each day) and 4 mg (for smokers of 25 or more cigarettes each day) and also is available in exciting flavors such as Fresh Mint, Fruit Chill, and Cinnamon Surge. New Nicorette mini Lozenge is available in two strengths -- 2 mg and 4 mg.  The 2 mg dosage is for smokers who usually have their first cigarette more than thirty minutes after waking up.  The 4 mg dosage is for smokers who usually have their first cigarette within thirty minutes of waking up.  Nicorette mini Lozenge is approved by the FDA to help control cravings associated with quitting smoking.  The U.S. Public Health Service Guidelines recommend NRT products like Nicorette mini Lozenge as a first-line treatment for smoking addiction in the U.S.  New Nicorette mini Lozenge Doubles Your Chances of Quitting and Dissolves Up to 3x Faster than Other Stop Smoking Lozenges. Learn more at Nicorette.com.  Speed of dissolution does not infer speed of relief.  Use as directed. Support program increases chances of success. Individual results may vary.

About GlaxoSmithKline® Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies.  Its more than 30 well-known brands include the leading smoking cessation products, Nicorette®, NicoDerm®CQ®, and Commit®, as well as many products such as alli®, Aquafresh®, Sensodyne®, and TUMS® -- which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline®

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: GSK.com.

SOURCE GlaxoSmithKline Consumer Healthcare